MD, UBC 1979, Master of Health Science, UBC 1985, FRCPC Community Medicine (Public Health and Preventive Medicine), UBC 1987. Led and managed public health services as a Medical Health Officer in various capacities, communities and stages of regionalization and integration in BC for 27 years. Retired Dec 31 2010 after 8 years as Chief Medical Health Officer for Fraser Health Region. Research activities and publications were primarily with vaccines and communicable diseases, although devoted much time to advocacy for early childhood development and other social determinants of population health. Clinical Professor (now Emeritus) with UBC School of Population and Public Health, involved mostly with resident training.

  • UBC James M. Robinson Memorial Award for Significant Contributions to Public Health
  • B.C. Provincial Health Officer Lifetime Achievement Award for Excellence in Public Health
168 – 2206 East Mall
Vancouver, BC V6T 1Z3

Selected References
Langley JM, Sales V, McGeer A, Guasparini R, Predy G, Meekison W, et al. A dose-ranging study of a subunit respiratory syncytial virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age. Vaccine. 2009 Sep 25;27(42):5913-9.
Patrick DM, Petric M, Skowronski DM, Guasparini R, Booth TF, Krajden M, et al. An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus. Can J Infect Dis Med Microbiol. 2006 Nov;17(6):330-6.
Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine. 2000 Jan 31;18(14):1312-9.
Halperin SA, Scheifele D, Barreto L, Pim C, Guasparini R, Medd L, et al. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J. 1999 Sep;18(9):772-9.
Scheifele DW, Guasparini R, Lavigne P. A comparative study of PENTA vaccine booster doses given at 12, 15, or 18 months of age. Vaccine. 1999 Feb 12;17(6):543-50.
Krahn M, Guasparini R, Sherman M, Detsky AS. Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Am J Public Health. 1998 Nov;88(11):1638-44.
Halperin SA, Davies HD, Barreto L, Guasparini R, Meekison W, Humphreys G, et al. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. J Pediatr. 1997 Apr;130(4):525-31.
Guasparini, R., Paul, M., Thomas, B. Tuberculosis in Central Fraser Valley Health Unit High School. BC Health and Disease Surveillance 1995; 4(2):18-26.
Scheifele DW, Meekison W, Guasparini R, Roberts A, Barreto L, Thipphawong J, et al. Evaluation of booster doses of haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine. 1995 Jan;13(1):104-8.
Bell A, Guasparini R, Meeds D, Mathias RG, Farley JD. A swimming pool-associated outbreak of cryptosporidiosis in British Columbia. Can J Public Health. 1993 Sep-Oct;84(5):334-7.
Scheifele D, Bjornson G, Guasparini R, Meekison W. Is haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) compatible with diphtheria-pertussis-tetanus vaccine in young infants? Pediatr Infect Dis J. 1993 Nov;12(11):952-4.
Moorehead WP, Guasparini R, Donovan CA, Mathias RG, Cottle R, Baytalan G. Giardiasis outbreak from a chlorinated community water supply. Can J Public Health. 1990 Sep-Oct;81(5):358-62.
Meekison W., Hutcheon M., Guasparini R., Arnott M., Scheifele D., Grace M., Humphreys G., Barreto L. Postmarketing Surveillance of Adverse Reactions to ProHIBiT Vaccine in British Columbia. Canadian Medical Association Journal 1989;141:927-9.
Guasparini, R., Wagner, K., Rice, S., Proctor, E. Surveillance for Cryptosporidiosis in 100 Mile House. BC Disease Surveillance 1988; 9(3):25-27.
Fogel, D., Issac-Renton, J., Guasparini, R., Moorehead, W. P., Tanner, K., Ongerth, J. Cryptosporidium Oocysts Isolated from a Community’s Drinking Water Source. BC Disease Surveillance 1988;9(3):22-24.
Guasparini R, Sheps SB, Mathias RB, Glick N. Measles outbreak in a vancouver school population: Relative risk and vaccine efficacy. Can J Public Health. 1988 Jan-Feb;79(1):26-30.
Guasparini, R., Traviss, M., Nicoll, J. Measles in Prince Rupert, Masset and Queen Charlotte City BC Disease Surveillance 1984;7(5):114-121.

shared supervision of Public Health and Preventive Medicine  Residents’ 710 Academic half day.